The abstract is read at the publisher; the summary is JClub's.
In advanced gastrointestinal cancer malignant ascites, an IL-10–enriched effector dysfunction immunophenotype is exclusive to cancer patients, unlike GZMB-enriched responses seen in nonmalignant hepatitis.
- Why it matters: Malignant ascites reflects peritoneal cancer–immune interactions, but functional immune states linked to disease versus nonmalignant inflammation are not well defined.
- What they did: Using CyTOF on ascitic immune cells from patients with advanced gastrointestinal cancers, nonmalignant hepatitis (NMH), and healthy control PBMCs, the study mapped three stimulation-linked functional immunophenotypes and aligned them with ascitic cytokine profiles.
- The result: Cancer-associated ascites also harbors persistent cancer-binding IgG, with IgG binding to autologous ascitic PDAC cells and multiple allogeneic PDAC cell lines, supporting a sustained humoral immune niche.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.